Tag: release

NEW YORK, June 26, 2026 (GLOBE NEWSWIRE) -- 21shares, one of the world’s largest issuers of cryptocurrency exchange traded products (ETPs), today announced the following shareholder distributions for the 21shares Ethereum ETF (TETH), 21shares Solana ETF (TSOL), 21shares Hyperliquid ETF (THYP), 21shares Sui ETF (TSUI), and 21shares Polkadot ETF (TDOT). Distributions consist of staking rewards earned from staked ETH, SOL, HYPE, SUI, and DOT tokens by each fund, respectively.

TORONTO, June 26, 2026 (GLOBE NEWSWIRE) -- Euro Sun Mining Inc. (TSX: ESM) (“Euro Sun” or the “Company”) is pleased to provide the voting results from its 2026 annual general meeting of shareholders in accordance with the policies of the Toronto Stock Exchange.

TORONTO, June 26, 2026 (GLOBE NEWSWIRE) -- (TSX: PIC.A; PIC.PR.A) Premium Income Corporation (the “Fund”) announces results of operations for the six months ended April 30, 2026. Increase in net assets attributable to holders of Class A shares amounted to $69.8 million or $3.91 per Class A share. Net assets attributable to holders of Class A shares as at April 30, 2026 were $229.4 million or $12.39 per Class A share ($11.26 per Class A share after giving effect to the May 2026 Share Split). Cash distributions of $0.64 per Preferred share and $0.52 per Class A share were paid during the period.

MONTEVIDEO, Uruguay, June 26, 2026 (GLOBE NEWSWIRE) -- DLocal Limited (“dLocal”, “we”, “us”, and “our”) (NASDAQ:DLO), a leading cross-border financial infrastructure platform connecting global merchants to emerging markets, today announced that the Company was added as a member of the US small-cap Russell 2000® Index, effective when the US market opens on June 29 as part of the 2026 Russell indexes reconstitution. Membership in the Russell 2000® Index is based on membership in the broad-market Russell 3000® Index. The stock also was automatically added to the appropriate growth indexes.

BEDMINSTER, N.J., June 26, 2026 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (the “Company”) (NYSE American: MTNB) announced today that on June 24, 2026, it received a notice (the “Notice”) from the NYSE American LLC (the “NYSE American”) stating that the Company is not in compliance with the NYSE American continued listing standards set forth in Section 1003(a)(ii) of the NYSE American Company Guide (the “Company Guide”) requiring a company to have stockholders’ equity of at least $4.0 million if it has reported losses from continuing operations and/or net losses in three of its four most recent fiscal years. As of March 31, 2026, the Company had stockholders’ equity of $3.02 million and has had losses in the most recent five fiscal years ended December 31, 2025. As previously disclosed, the Company is also not in compliance with Section 1003(a)(iii) of the Company Guide requiring a company to have stockholders’ equity of at least $6.0 million if it has reported losses from continuing operations and/or net losses in its five most recent fiscal years. As of December 31, 2025, the Company had stockholders’ equity of $4.83 million and has had losses in the most recent five fiscal years ended December 31, 2025. Due to its non-compliance with Sections 1003(a)(ii) and 1003(a)(iii) of the Company Guide, the Company is subject to the procedures and requirements of Section 1009 of the Company Guide.

MONTRÉAL, June 26, 2026 (GLOBE NEWSWIRE) -- Rogers Sugar Inc. (the “Company” or “Rogers Sugar”) (TSX: RSI) today announced that the ‘’United Food and Commercial Workers Union’’ representing the employees at its Taber sugar beet refinery has ratified the extension of its current collective agreement to March 2032.

MONTRÉAL, 26 juin 2026 (GLOBE NEWSWIRE) -- Rogers Sugar Inc. (la “Société” ou “Rogers Sugar”) (TSX: RSI) annonce aujourd’hui que le syndicat des Travailleurs et travailleuses unis de l’alimentation et du commerce, représentant les employés de sa raffinerie de sucre de betterave de Taber, a ratifié la prolongation de la convention collective actuelle jusqu’en mars 2032.

International patients gain access to coordinated medical expertise, advanced treatment options, and personalized support across Acibadem hospitals in Türkiye.